PATIENTS CAN ONLY CLAIM THEIR PAID CONTRIBUTION, NOT THEIR EXCESS
General information
The pharmacist has dispensed Fludrace® 31,25 and/or 62,5 microgram to the patient. The health insurer will not…
Reimbursement Scheme Acecort®
The health insurer fully reimburses Acecort® 1, 2 and 3 mg as off March 1, 2023. The reimbursement by TBR Nederland will therefore be discontinued.
Conditions
This…
Reimbursement Scheme Forxiga® (dapagliflozine) 10 mg for the treatment of HFpEF (LVEF >40%)
The health insurer does not yet fully reimburse Forxiga® (dapagliflozin) 10 mg for the treatment of HFpEF…
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine
Check Medicine Expenses
General information
The pharmacist has dispensed Lokelma® 5g or 10g…
Contact number for Clients
+31 (0)88 - 00 267 02
TBR Nederland is part of Phareso, PHArmaceutical REimbursement SOlutions. Phareso is an expert in offering payment solutions for the…
Reimbursement Scheme Isturisa®
The health insurer does not fully reimburse Isturisa® 1mg, 5mg and 10mg. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the…
Termination TerugBetaalRegeling Forxiga® - Chronic Kidney Disease
From May 1st 2022 onwards, Forxiga® (dapagliflozine) 10 mg for the treatment of chronic kidney disease (CKD) is fully reimbursed by…
Extension to TerugBetaalRegeling Elvanse®
The health insurer does not fully reimburse Elvanse® 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg. The manufacturer of this medicine has therefore…
Reimbursement Scheme Ontozry® (12.5mg/25mg, 50 mg, 100 mg, 150mg)
The health insurer does not fully reimburse ONTOZRY® (12.5mg/25mg, 50 mg, 100 mg, 150mg). The producer of this medicine has…
Reimbursement Scheme Jardiance® (empagliflozin)10 mg for patients with HFpEF (Ejection fraction>40%)
The health insurer does not yet fully reimburse Jardiance (Empagliflozin)® 10 mg for the…
